Are you struggling with the discomfort and inconvenience of Benign Prostatic Hyperplasia (BPH)? Optilume BPH offers a cutting-edge, minimally invasive solution that goes beyond traditional treatments. Discover how this FDA-approved procedure can enhance your quality of life.
Optilume BPH: A Minimally Invasive Breakthrough
The Optilume is an inventive approach to BPH treatment. It is a minimally invasive FDA approved BPH procedure that uses a drug-coated balloon to expand the prostatic channel. Once inserted through the urethra via a cystoscope, and placed in the prostate, the ballon is inflated, releasing and transferring the drug (Paclitaxel) to the tissue. Expansion of the balloon creates a large open channel and the drug prevents regrowth of the prostatic tissue. This combination maintains long term patency. The Optilume device offers surgical results with reduced side effects.


Optilume BPH is FDA approved for men 50 years or older, and for prostate sizes up to 80g. It has several sizes which correspond to the prostate length in centimeters.